Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-16

Clinical Trial Update: Antineoplaston Therapy in Treating Children With Visual Pathway Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antineoplaston therapy for children with visual pathway glioma completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Visual Pathway Glioma | Phase 2 | Status: COMPLETED | Results posted: 2016-12-16